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ABSTRACT 
IMPLEMENTING NERVE BLOCKS FOR PATIENTS UNDERGOING A 
BILATERAL MASTECTOMY WITH IMMEDIATE RECONSTRUCTION:  A 
PRACTICE CHANGE 
by Corey Beene Auerswald 
December 2017 
Breast cancer is one of the most commonly diagnosed cancers in women. A 
mastectomy is one of the first line treatments for breast cancer, but it is associated with 
considerable postoperative pain. Literature suggests current methods of pain management 
are ineffective and regional anesthesia can help reduce postoperative complications 
following a bilateral mastectomy with immediate reconstruction. Information from the 
literature review was used to inform five anesthesia providers at a rural hospital in 
Mississippi about the benefits of regional anesthesia for patients having a mastectomy.  A 
presentation was given to anesthesia providers regarding the benefits of paravertebral 
blocks (PVB) for patients undergoing a bilateral mastectomy with immediate 
reconstruction. Investigator developed questionnaires were used to determine how many 
times nerve blocks were provided for patients undergoing a bilateral mastectomy with 
immediate reconstruction one month before and one month after the intervention. 
Descriptive statistics were used to interpret the results of the questionnaires. One month 
following the presentation, 20 patients at the surgery center had a bilateral mastectomy 
with immediate reconstruction. All 20 of these patients received nerve blocks. Anesthesia 
providers also reported these patients had less postoperative complications than patients 
who did not receive a block. Although anesthesia providers at this facility implemented 
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Pecs I, Pecs II, and serratus plane blocks instead of PVB blocks for this patient 
population, results from this project show when presented with EBP, anesthesia providers 
are willing to make a practice change to improve patient outcomes.  
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CHAPTER I – INTRODUCTION 
Background and Significance 
Breast cancer is one of the most commonly diagnosed cancers in women. In the 
United States, breast cancer alone is expected to account for 30% all new cancer 
diagnoses in women (American Cancer Society [ACS], 2017).  In 2017, approximately 
252,710 new cases of invasive breast cancer will be diagnosed in women, as well as an 
estimated 63,410 additional cases of in situ breast cancer. Mississippi is expected to have 
2340 new breast cancer diagnosis in 2017 (ACS, 2017). 
A mastectomy is one of the first-line surgical treatments for breast cancer 
(Steiner, Weiss, Barrett, Fingar, & Davis, 2016). Recently, mastectomy rates increased, 
especially among younger women. Most patients with breast cancer having a mastectomy 
will require an overnight stay for management of pain, nausea, and vomiting (Boughey et 
al., 2009). Furthermore, patients undergoing a bilateral mastectomy with immediate 
reconstruction experience longer hospital stays and more postoperative complications 
than patients undergoing a unilateral mastectomy (Sharpe et al., 2014).  
Problem Statement and Needs Assessment 
A mastectomy is associated with considerable postoperative pain. Approximately 
40% of mastectomy patients experience significant acute postoperative pain, indicating 
current methods of treating postoperative pain are not effective (Schnabel, Reichl, 
Kranke, Pogatzki-Zahn, & Zhan, 2010). Additionally, “acute postoperative pain is an 
important risk factor for the development of persistent chronic postoperative pain in 
women after breast surgery” (Schnabel et al., 2010, p 8).  The use of general anesthetics 
can cause significant postoperative nausea and vomiting (PONV), and opioid use after 
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surgery is associated with respiratory depression, nausea, and vomiting. Several studies 
and anesthesia textbooks also suggest surgical stress, general anesthetics, and opioids can 
decrease immune function and lead to cancer recurrence (Butterworth, Mackey, & 
Wasnick, 2013; Exadaktylos, Buggy, Moriarty, Mascha, & Sessler, 2006; Fodale, 
D’Arrigo, Triolo, Mondello, & La Torre, 2010). Regional anesthesia can reduce 
postoperative complications for patients undergoing a bilateral mastectomy with 
immediate reconstruction. However, an informal survey comprised of seven staff 
certified registered nurse anesthetist (CRNAs) conducted by the investigator at various 
hospitals in Mississippi revealed these anesthesia providers were unaware of these 
benefits. Also, several of these CRNAs expressed a desire to learn about regional 
anesthesia for this patient population.  
Clinical Question 
Will anesthesia providers who have received information about paravertebral 
blocks (PVBs) make a practice change to incorporate PVBs into the plan of care for 
patients undergoing a bilateral mastectomy with immediate reconstruction 1 month after 
receiving the information?  Regional anesthesia is currently used for various surgical 
procedures and can be the sole anesthetic or used in combination with general anesthesia 
(GA). A PVB is a type of regional nerve block which can provide postoperative pain 
control for patients undergoing a mastectomy. Administration of a PVB requires 
injections at each vertebral level that corresponds to the dermatome needing be 
anesthetized. For example, “a simple mastectomy would require blocks at levels T3-6; for 
axillary node dissection, additional injections should be made from C7 through T2” 
(Butterworth et al., 2013, p. 1019).  PVBs can provide analgesia, reduce the stress 
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response to surgery, and decrease the need for opioids and general anesthetic 
requirements. Other benefits, such as, improved postoperative pulmonary function, 
decreased incidence of chronic pain, and decreased cancer recurrence may be attributed 
to PVBs (Aufforth et al., 2012; Boughey et al., 2009; Exadaktylos et al., 2006).  
Recently, utilization of PVBs for breast surgery increased (Bolin, Harvey, & 
Wilson, 2015). Hospitals such as the Mayo Clinic, MD Anderson, and Duke University 
Hospital use PVBs routinely, when appropriate, for patients having a mastectomy (Penne, 
2009). Dr. Goravanchi, a physician at MD Anderson, stated: 
For patients who get the paravertebral block, we see a dramatic reduction in the 
pain medication they take after surgery, thus eliminating the many side effects 
that come with that. Plus, patients are often less anxious going into surgery 
because they know they will wake up virtually pain-free and go home that way 
(Penne, 2009, para. 19). 
 Although a PVB can provide many benefits, there are some risks. These risks 
include hypotension, pneumothorax, block failure, and epidural spread. According to 
Bolin et al. (2015), a pneumothorax is frequently the most dreaded complication of a 
PVB, but the incidence of developing a pneumothorax after a PVB is only 0.5%. The 
incidence of hypotension is reported to be 2-5% (Cheng & Ilfeld, 2016).  However, the 
use of an ultrasound machine can enhance the safety and improve the quality of the 
block. Overall, PVBs are generally considered a low risk procedure, and the majority of 
complications are often resolved within 24 hours.   
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Purpose of the Project 
The primary goal of this project was to create a practice change in which 
anesthesia providers incorporate PVBs into the plan of care for patients undergoing a 
bilateral mastectomy with immediate reconstruction. Informing anesthesia providers 
about the impact of postoperative complications in this population and providing 
education regarding the benefits regional anesthesia offers can create an awareness that a 
practice change needs to be made. Providing onsite training can further increase the 
likelihood PVBs will be performed for these patients.  
A secondary goal of this project was to improve postoperative outcomes for 
patients undergoing a bilateral mastectomy with immediate reconstruction. A bilateral 
mastectomy with immediate reconstruction is associated with more complications than a 
unilateral mastectomy and an increased incidence of chronic pain or post mastectomy 
pain syndrome (Kahn, 2011; Sharpe et al., 2014). In bilateral mastectomy patients, “69% 
reported pain at 2 years, which affected sleep in 36% and daily activities in 22%”, and the 
women who are affected the greatest by chronic pain are the ones who opt for a 
contralateral mastectomy (Kahn, 2011, p. 2134). Several studies have reported the 
effectiveness of PVB in decreasing postoperative complications in this population. If 
implemented, PVBs can improve patient satisfaction, increase revenue, and decrease cost 
to the facility. 
Review of Literature 
An initial literature search was performed using PubMed and Primo at The 
University of Southern Mississippi in order to obtain articles involving patients 
undergoing a mastectomy, PVBs, and postoperative outcomes. Search terms used were 
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mastectomy, nerve block, postoperative, pain, nausea, and vomiting. Of the 17 articles 
located using PubMed, 12 were within published within the last 10 years. This number 
was further reduced to five articles due to relevance. Thirteen articles published within 
the last 10 years were found using Primo. Six of these articles were duplicates of the 
PubMed search and six were not relevant. A total of six articles were reviewed from this 
initial search. These articles revealed PVBs were most beneficial to patients having more 
extensive surgery, such as a bilateral mastectomy with immediate reconstruction. This 
finding led to a change in the focus of the project from mastectomy patients to patients 
undergoing a bilateral mastectomy with immediate reconstruction. Additional searches of 
Academic Premiere, Health Source, MEDLINE, CINAHL, and PubMed using 
combinations of the terms bilateral mastectomy, mastectomy or breast surgery, 
paravertebral block, postoperative, chronic pain, pain, and cancer recurrence resulted in 
the discovery of 12 new relevant articles. These articles can be found in the synthesis 
matrix (Appendix B).  
Postoperative Pain 
Studies conducted by Beyaz, Ergonenc, Altintoprak, & Erdem (2012); 
Bhuvanseswari, Wig, Mathew, & Singh (2012); Boughey et al., (2009); Parikh, Sharma, 
Guffey, & Myckatyn  (2016); Pei et al. (2015); Schnabel et al. (2010); Tahiri et al. 
(2011); and Terkawi et al. (2015) included various types of mastectomies and showed 
less postoperative pain for patients in the group receiving a PVB compared to those who 
did not receive a PVB. Agarwal et al. (2015) discovered for patients undergoing a 
unilateral or bilateral mastectomy those in the PVB group experienced less postoperative 
pain immediately, but not on postoperative day (POD) 1 when compared to those who 
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did not receive a PVB. In another study, patients in the PVB group had less postoperative 
pain scores than the non-PVB group, but no statistical significance was found (Shimizu et 
al., 2015). Nine studies found patients in the PVB group used less pain medications 
postoperatively (Aufforth et al., 2012; Beyaz et al., 2012; Fahy et al., 2014; Glissmyer et 
al., 2015; Parikh et al., 2016;  Schnabel et al., 2010; Tahiri et al., 2011; Terkawi et al., 
2015). Furthermore, the greatest reduction in narcotic use was seen in patients 
undergoing immediate reconstruction (Fahy et al., 2014; Parikh et al., 2016). Patients 
receiving a PVB were converted to oral narcotics sooner (Coopey et al., 2013; Parikh et 
al., 2016) and required less intraoperative opioids and general anesthetics (Pei et al., 
2015; Shimizu et al., 2015; Terkawi et al., 2015). Two of the studies did not address 
postoperative pain (Exadaktylos et al., 2006; Fodale et al., 2014). 
 Six studies reported less chronic pain after a mastectomy with a PVB. Patients 
receiving a PVB reported 20- 50% reduction in chronic pain (Beyaz et al., 2012). Meta-
analyses by Schnabel et al. (2010) and Terkawi et al. (2015), revealed the relative risk for 
chronic pain was lower in the PVB group 6 months after surgery. Bolin et al. (2015); 
Schnabel et al. (2010); Shimizu et al. (2015) discovered less chronic pain 12 months after 
surgery in patients  who received GA in addition to a PVB. Karmakar et al., (2014) 
concluded patients who receive a PVB report less severe chronic pain, exhibit fewer 
symptoms and signs of chronic pain, and also experience better physical and mental 
health related quality of life (HQROL). 
Postoperative Nausea and Vomiting 
Four studies noted PONV was significantly less in the PVB group (Beyaz et al., 
2012; Coopey et al., 2013; Schnabel et al., 2010; Terkawi et al., 2015). Likewise, higher 
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antiemetic use was required for patients not receiving a PVB (Fahy et al., 2014).  
Aufforth et al. (2015) noted slightly less PONV for the PVB group. PONV was not 
statistically significant between the two groups in two of the studies (Bhuvanseswari et 
al., 2012; Boughey et al., 2009). Eight of the 16 articles did not address PONV. 
Length of Stay 
The length of stay (LOS) for patients receiving a PVB was significantly less than 
those who did not receive a PVB (Beyaz et al., 2012; Boughey et al., 2009; Coopey et al., 
2013; Glissmyer et al., 2015; Parikh et al., 2016; Terkawi et al., 2015). Boughey et al. 
(2009), discovered patients having extensive breast surgery were less likely to require an 
overnight stay if they received a PVB and were discharged sooner than those receiving 
GA alone. Of the studies looking at chronic pain, only one reported patients in the non-
PVB group were discharged sooner than the PVB group (Fahy et al., 2014). However, 
this study included patients undergoing various types of mastectomies and patients 
having a less extensive surgery were more likely to be discharged sooner than those 
undergoing a bilateral mastectomy. 
Cancer Recurrence 
Surgery causes stress to the body, and studies show after surgery recurrence of 
neoplastic disease can occur. “The body’s response to surgical stress causes the release of 
chemical mediators, which determine the upregulation of malignant pathways, disruption 
of tumor homeostasis, and promotion of cancer recurrence” (Fodale et al., 2014, p. 2).  
Immune surveillance refers to the body’s ability to recognize self from non-self or the 
cancer cells. The body then tries to eliminate the cancer cells. Since surgery causes 
immunosuppression, some tumor cells are able to evade immune control (Fodale et al., 
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2014). Volatile anesthetics can further decrease immune function and pain can inhibit 
immune surveillance. Regional anesthesia can block the body’s neuroendocrine response 
to surgical stress by blocking transmission of neuronal signals to the central nervous 
system. Locoregional anesthesia can help preserve natural killer (NK) cell function and 
decrease the amount of GA required intraoperatively. Therefore, a PVB is associated with 
lower risk of cancer recurrence (Fodale et al., 2014; Schnabel et al. 2010). Exadaktylos et 
al. (2006) reported patients receiving a  PVB in addition to GA group had less cancer 
recurrence/metastasis (3/50) compared to the GA group (19/50). Furthermore, the PVB 
with GA group had a slower time to recurrence than the GA group (Exadaktylos et al., 
2006). A multicenter randomized trial is currently being conducted in the U.S. to 
determine the efficacy of PVBs in reducing cancer recurrence. 
Other Regional Techniques Used for Breast Surgery 
Wound Infiltration is the direct infiltration of local anesthetic at the surgical site 
which avoids the complications associated with other regional techniques. However, data 
from 15 randomized controlled trials (RCTs) failed to prove wound infiltration was 
effective in reducing postoperative pain (Cheng & Ilfeld, 2016). Wound infusion involves 
the placement of a catheter at the surgical site and allows for an infusion or boluses of 
local anesthetic to be administered. Like wound infiltration, studies determined wound 
infusion did not provide statistically significant benefits for breast surgery (Cheng & 
Ilfeld, 2016).  
Pectoral Nerve Blocks (Pecs) are an interfacial plane block and have been used as 
an alternative to a PVB for simple mastectomy procedures and chest wall procedures 
involving the axilla. A Pecs I block anesthetizes the pectoral nerves and can be used for 
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mastectomies that do not involve axillary node dissection (Cheng & Ilfeld, 2016). A 
modified version of the Pecs I block is the Pecs II block. A Pecs II block anesthetizes the 
medial and lateral pectoral nerves and the lateral branches of the intercostal nerves by 
injecting local anesthetic between the pectoralis minor and anterior serratus muscles. A 
Pecs II block can be used for more extensive breast surgery involving the axilla (Bolin et 
al., 2015). However, only one RCT involving radical mastectomy procedures has been 
concluded a Pecs block with GA reduces postoperative pain compared to GA alone. A 
Pecs I and Pecs II block lack the risk of sympathectomy, which can cause hypotension 
and bradycardia, and can still be performed if the patient is anticoagulated. Risks 
associated with Pecs II blocks are thoracoacromial artery injection, pneumothorax, and 
puncture of the axillary fascia. As of 2015, no formal studies comparing Pecs II blocks to 
PVBs were identified in the literature. Unlike a PVB, Pecs I and II blocks cannot be used 
as a sole anesthetic for a mastectomy (Bolin et al., 2015). This literature review found no 
evidence to conclude Pecs I or II blocks were superior to PVBs for reducing 
postoperative complications in patients undergoing a bilateral mastectomy with 
immediate reconstruction.  
A thoracic epidural infusion has been documented as an effective technique for 
major breast surgery. Although, thoracic epidurals are effective in decreasing 
postoperative complications, they carry more side effects than PVBs. Side effects of a 
thoracic epidural include profound hypotension, headache, spinal cord injury, and spinal 
cord hematoma (Bolin et al., 2015). Also, a thoracic epidural can only be used in a 
hospital setting.  
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Thoracic epidurals and PVBs are the only techniques confirmed to provide 
reliable, effective postoperative pain relief for breast procedures, and PVBs are the only 
regional technique proven to decrease post mastectomy pain within 12 months (Bolin et 
al., 2015; Cheng & Ilfeld, 2016). Literature revealed Pecs blocks are becoming more 
popular for chest wall procedures, but there is a lack of evidence to support they are 
better than PVBs at decreasing postoperative complications in patients undergoing 
extensive breast surgery. According to Bolin et al. (2015), PVBs are the “gold standard” 
regional technique of choice for breast procedures when compared to other techniques. 
This literature review revealed PVBs are most effective in reducing postoperative 
complications, such as postoperative pain, PONV, chronic pain, and cancer recurrence, 
and LOS in patients having a mastectomy with immediate reconstruction. 
Theoretical Framework 
The model for evidence-based practice (EBP) change, developed by Rosenwurm 
and Larrabee, is the change theory that was used for this project to create a practice 
change. The first step is to assess the need for a change in practice (Melnyk & Fineout-
Overholt, 2015, p. 288). This step includes identifying the practice problem. For this 
project, the problem was a lack of awareness among anesthesia providers regarding the 
evidence that PVBs can improve postoperative outcomes for patients undergoing a 
bilateral mastectomy with immediate reconstruction. Moreover, the problem should be a 
priority to anesthesia providers and the institution. One way to make this practice change 
a priority is to inform anesthesia providers and the hospital they can bill separately for 
these blocks because they are provided for postoperative pain. Therefore, providing a 
PVB can increase reimbursement. Also, a PVB used in addition to GA could be cost 
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saving to the institution by decreasing the amount of narcotics used and length of stay for 
patients. 
Next, a review of current literature is done to identify EBP.  The 3rd step involved 
appraising the literature; synthesizing the evidence; and assessing the benefits, feasibility, 
and risks of implementing the practice change (Melnyk & Fineout-Overholt, 2015). Step 
4 of the model for EBP was designing a practice change by identifying resources, design 
evaluation, and designing a plan for implementation. The new practice should be 
supported by the evidence from Step 3 (Melnyk & Fineout-Overholt, 2015). 
Step 5 involves implementation and evaluation of the practice change. In this step, 
CRNAs and anesthesiologist at the institution would provide PVBs in addition to GA to 
bilateral mastectomy patients having immediate reconstruction. The practice change 
would then be evaluated to see if it is cost saving to the institution, increases revenue, and 
improves patient outcomes. Finally, the practice change would be integrated and 
maintained. This step also includes monitoring outcomes periodically and disseminating 
results of the project outside of the institution (Melnyk & Fineout-Overholt, 2015). 
Doctor of Nursing Practice Essentials 
This doctoral project meets the eight Doctor of Nursing Practice (DNP) essentials 
which are listed in Appendix A. The main essentials this project addressed were Essential 
II, III, and VI. Essential II: Systems Thinking, Healthcare Organizations, and the 
Advanced Practice Nurse Leader guides DNP nurses to assess current healthcare policies 
and create policies that improve healthcare outcomes at an organizational level 
(Zaccagnini & White, 2014). For example, this project aimed to create a practice change 
which incorporates PVBs for patients undergoing a bilateral mastectomy in order to 
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improve postoperative outcomes. Essential III: Clinical Scholarship and Analytical 
Methods for Evidence-Based Practice involves research translation and the dissemination 
and implementation of new knowledge (American Association of Colleges of Nursing, 
2006). A review of literature found PVBs can improve postoperative outcomes for 
mastectomy patients. These findings were disseminated to CRNA’s to improve practice. 
Essential VI: Interprofessional Collaboration for Improving Patient and Population 
Health Outcomes was met through collaboration with physicians, anesthesiologist, and 
CRNAs so that PVBs can be implemented for patients having a bilateral mastectomy 
with immediate reconstruction to decrease LOS, improve postoperative outcomes, and 
increase patient satisfaction. 
Summary 
Surgery for breast cancer is associated with a significant amount of postoperative 
complications. DNP prepared nurses use nursing science to improve patient outcomes, 
and this project sought to create a practice change to implement PVBs for patients 
undergoing extensive breast surgery by educating anesthesia providers about the benefits 
PVBs can provide to these patients. By following the steps in the model for EBP change, 
nerve blocks were implemented in order to decrease postoperative complications for 
patients undergoing a bilateral mastectomy with immediate reconstruction.  
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CHAPTER II - METHODOLOGY 
Overview 
The literature review has shown PVBs are superior to other methods of regional 
anesthesia and can improve postoperative outcomes for breast cancer patients undergoing 
breast surgery. This project aimed to create a practice change to implement PVBs by 
informing anesthesia providers about the benefits of PVBs for bilateral mastectomy 
patients having immediate reconstruction. Once implemented, PVBs can fulfill the 
secondary goal of this project which was to improve postoperative outcomes for those 
undergoing breast cancer surgery with reconstruction. 
Target Population 
The target population for this study was anesthesia providers, CRNAs and 
anesthesiologist, in Mississippi. The convenience sample used for this project consisted 
of anesthesia providers at a 111 bed hospital in the Southern U.S.  Healthcare providers 
who were not an anesthesiologist or CRNA were excluded. Those excluded from the 
study included registered nurses and physicians. 
Design 
An in-service was held for anesthesia providers at the facility detailing the 
benefits of PVBs and how to perform them. The in-service included information 
compiled from the literature review. Immediately following the in-service, anesthesia 
providers were asked to perform PVBs for bilateral mastectomy patients undergoing 
immediate reconstruction. A protocol was developed for administration of PVBs and is 
included in Appendix C. Training and a step by step guide for performing PVBs was 
provided from The New York School of Regional Anesthesia’s website at 
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www.nysora.com.  Additional onsite training was provided by a healthcare provider 
employed at the hospital with knowledge of PVBs. 
Anesthesia providers were asked to complete an investigator developed 
questionnaire regarding their anesthesia practice one month prior to the presentation. The 
initial questionnaire can be found in Appendix D. A tally sheet was provided to the 
anesthesia providers in order to track the number times they provided an anesthetic to a 
patient undergoing a bilateral mastectomy with immediate reconstruction over a one 
month time period. After the one month time period, an investigator created questionnaire 
was administered to the anesthesia providers to determine if they had performed any type 
of nerve block for patients having breast cancer surgery with immediate reconstruction. 
The follow-up questionnaire can be found in Appendix E. Completion of the 
questionnaire indicated informed consent to participate in the study. 
Data was gathered from the tally sheet and the questionnaire. Information 
obtained from the questionnaire included how many times a nerve block was provided, 
whether or not the anesthesia provider felt the in-service was effective, and whether the 
anesthesia provider felt the nerve blocks decreased postoperative complications.  
Descriptive statistics was used to determine the percentage of anesthesia providers 
changed their practice to incorporate nerve blocks.   
Design-Ethical Considerations – Protection of Human Subjects (IRB) 
Approval for the study was obtained from The University of Southern Mississippi 
(17022302, Appendix F) and the facility (Appendix G). All questionnaires were 
anonymous. Data obtained for this project will be deleted and/or shredded 6 months after 
completion of graduation requirements. 
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If the nerve blocks are administered preoperatively for postoperative pain control, 
extra income can be generated for the anesthesia provider and the facility. Training for 
administration of PVBs required additional time for the anesthesia provider and could be 
considered an inconvenience. Because the procedure was new to this facility, there could 
have been a learning curve. During this time, patients could have been unsatisfied with 
their anesthetic, which could reflect negatively on the anesthesia provider. On the other 
hand, several sources have sited that PVBs are easy to learn, which could mean patient 
satisfaction would improve. Additionally, there were potential risks to the patient 
receiving a PVB, such as pneumothorax, hypotension, or failed anesthetic. However, 
there is a low risk for developing these complications especially if an ultrasound machine 
is used. 
Assumptions 
One assumption of this project was the postoperative care of bilateral mastectomy 
patients’ needs to be improved, and patients would agree to have a PVB. Another 
assumption was anesthesia providers will attend the in-service, and CRNAs would be 
authorized by the facility to administer PVBs. A list of assumptions can be found in the 
logic model (Appendix H). 
Resource Requirements 
Resources needed for this project included the anesthesia staff, preoperative 
rooms, and operating rooms (OR) rooms. Equipment, such as monitors, an ultrasound 
machine, and emergency airway equipment are needed to safely perform the blocks. 
Other supplies needed include sterile gloves, skin prep solution, emergency drugs, 
preoperative medications, nerve block medications, and nerve block needles. Another 
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resource required for this project was time. Administration of a PVB may require 
additional time, which could initially increase operating room turnover time and 
necessitate coordination between the anesthesia provider, surgeon, and OR staff.   
Summary 
Implementing PVBs for patients undergoing a bilateral mastectomy with 
immediate reconstruction required training, time, collaboration with other healthcare 
providers, and additional resources compared to current methods of anesthesia. However, 
PVBs can benefit patients by reducing postoperative complications and anesthesia 
providers due to additional revenue and increased patient satisfaction. Through the use of 
descriptive statistics, this study determined if anesthesia providers at a surgery center in 
the Southern U.S. made a practice change to incorporate PVBs into the plan of care for 
patients having extensive breast surgery in order to make inferences about the population 
of anesthesia providers in Mississippi. 
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CHAPTER III  - RESULTS 
Overview 
A 20-minute presentation was given to the anesthesia providers at a surgery center 
in Mississippi. The presentation was held in the conference room of the surgery center in 
the morning prior to any surgical cases. The sample included five of the six anesthesia 
providers. Ages ranged from 32-62, and the mean age was 52.2. Years of experience as 
an anesthesia provider were 6-33 with a mean of 25.2. Of the five participants, three 
(60%) were female and two (40%) were male. Participants were administered a 
questionnaire immediately following the presentation and again one month after the 
presentation. 
Statistical Analysis 
Descriptive statistics were used to interpret the results of the questionnaires. All 
five of the anesthesia providers who attended the presentation completed the initial 
questionnaire. Two of the five (40%) participants completed the 1-month questionnaire. 
Initial Questionnaire Results 
Anesthesia providers were asked to provide information for the month prior to the 
presentation. During this time period, a reported 22 patients had undergone a bilateral 
mastectomy with immediate reconstruction at the surgery center. None of these patients 
received a PVB. However, five (22.7%) of the 22 patients did receive a Pecs I, Pecs II, 
and serratus plane block. These nerve blocks were performed during a one week time 
period preceding the presentation. All of the anesthesia providers felt the information 
presented was relevant to their practice. There was no correlation between age or gender 
and administration of the nerve blocks. 
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Table 1  
Initial Questionnaire Results 
Initial Questionnaire Results 
 Total 
Participant 1 2 3 4 5  
Age 58 62 32 50 59  
Gender M F M F F  
Number of years as an 
anesthesia provider 
32 33 6 25 30  
Number patients who 
received a bilateral 
mastectomy with immediate 
reconstruction in the past 
month 
5 5 5 3 4 22 
Number of patients who 
received a PVB 
0 0 0 0 0 0 
Number of patients who 
received another type of 
nerve block 
1 1 2 0 1 5 
Was the information 
presented relevant to your 
practice 
Yes Yes Yes Yes Yes  
 
Follow-up Questionnaire  
One month following the presentation, a reported 20 patients at the surgery center 
had a bilateral mastectomy with immediate reconstruction. None of these patients 
received a PVB. Twenty (100%) of the patients received a Pecs I, Pecs II, and serratus 
plane block. All of these blocks were administered immediately following the induction 
of anesthesia. None of the blocks were used as the sole anesthetic for a bilateral 
mastectomy with immediate reconstruction. The only complication was minor skin 
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irritation at the injection site in one patient (0.05%). Anesthesia providers reported 
patients used less narcotics and a decrease in postoperative complications since the 
implementation of the nerve blocks. All anesthesia providers who participated in the 
follow-up questionnaire stated they would continue to perform nerve blocks for this 
patient population. There was no correlation between age and willingness to perform 
nerve blocks. However, all of the nerve blocks performed in the month following the 
presentation were done by the male anesthesia providers.  
Table 2  
Follow-up Questionnaire Results 
 
 
 
 
Follow-Up Questionnaire Results 
 Total 
Participant 1 2  
Age 58 32  
Gender M M  
Number of years as an 
anesthesia provider 
32 6  
Number patients who received a 
bilateral mastectomy with 
immediate reconstruction in the 
past month 
10 10 20 
Number of patients who 
received a PVB 
0 0 0 
Number of patients who 
received a different type of 
nerve block 
10 10 20 
 20 
Table 2 (continued) 
 
Summary 
Although this surgery center did not choose to administer PVBs, a practice 
change was made to incorporate Pecs I, Pecs II, and serratus plane blocks into the plan of 
care for bilateral mastectomy patients undergoing immediate reconstruction. Participants 
in this study reported a decrease in immediate postoperative complications for the 
patients who received these blocks. The next chapter will discuss recommendations, 
implications for future practice, and the conclusion. 
If patients received another type 
of nerve block, what type was 
performed 
Pecs I, Pecs II, 
and serratus 
plane block  
Pecs I, Pecs II, 
and serratus plane 
block 
 
Phase of Care when nerve block 
was provided 
Immediately 
after induction 
Immediately after 
induction 
 
Number of times a nerve block 
was contraindicated 
0 0 0 
Number of patients who 
experienced a complication 
related to the nerve block 
1 – minor skin 
irritation at 
injection site 
0 1 
Will you continue to perform 
Pecs I , Pecs II, and serratus 
plane blocks for this patient 
population 
Yes Yes  
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CHAPTER IV – DISCUSSION 
Overview 
The literature review revealed current methods of pain control following a 
bilateral mastectomy with immediate reconstruction to be suboptimal. The addition of 
regional anesthesia to the anesthetic plan for these patients has been shown to improve 
patient outcomes. Recently published articles have shown other types of nerve blocks to 
be effective in reducing immediate postoperative complications for patients having breast 
cancer surgery. Abdallah et al. (2017) demonstrated Pecs I and II blocks in addition to a 
serratus plane block were effective in reducing postoperative narcotic use and PONV for 
breast cancer patients in an ambulatory care setting. Kulhari, Bala, Bala, & Arora (2016) 
compared Pecs II blocks to PVBs for patients having a modified radical mastectomy and 
concluded Pecs II blocks to be just as effective as PVBs in reducing immediate 
postoperative pain. However, no articles to date have been found comparing the Pecs I 
and II blocks in addition to serratus plane block to PVBs for bilateral mastectomy 
patients undergoing immediate reconstruction.  Also, no studies have proven the Pecs 
blocks or serratus plane blocks to be effective in reducing chronic postoperative pain.  
This surgery center chose Pecs I, Pecs II, and serratus plane blocks over PVBs for 
patients undergoing a bilateral mastectomy because of the ease of administration and low 
risk of complications associated with the Pecs I, Pecs II, and serratus plane blocks.  In 
addition to determining whether or not a practice change was made, this project also 
obtained information about how patients have been impacted by the practice change.  
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Implications 
One month after the presentation, regional anesthesia was implemented for all 
patients undergoing a bilateral mastectomy with immediate reconstruction. Although all 
the participants in the initial questionnaire expressed interest in implementing nerve 
blocks for this patient population, the majority of the nerve blocks were administered by 
two providers. In the follow up questionnaire, these two anesthesia providers reported 
less narcotic use, less postoperative complication, and better outcomes when a Pecs I, 
Pecs II, and serratus plane block were used. These results are similar to those found by 
Kulhari et al. (2016). The healthcare providers at this facility determined nerve blocks to 
be so beneficial; they now offer nerve blocks for all mastectomy procedures. The facility 
where the nerve blocks were implemented has also begun to advertise improved pain 
control following a mastectomy.  
Limitations 
One limitation to this study is the small sample size. Low participation for the 
follow-up questionnaire was because the two providers participating in the follow-up 
questionnaire administered all the nerve blocks in the month following the presentation. 
An attempt was made to increase participation by providing the questionnaires during 
times that were convenient for the anesthesia providers. Some of the anesthesia providers 
reported on the initial questionnaire they had already begun performing Pecs I, Pecs II, 
and serratus plane blocks for patients undergoing a bilateral mastectomy with immediate 
reconstruction. Administration of the nerve blocks prior to the presentation and the 
decision to make a practice change may have been due to the surgeon’s involvement in 
the study. Ideally, the presentation would have been done prior to the surgeon’s arrival at 
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the facility, but due to scheduling conflicts it was not possible to present the material at 
an earlier date. Lack of materials and lack of buy in from healthcare providers and 
administrators may make these results difficult to replicate. However, this project is 
useful because it demonstrated that when presented with EBP, the anesthesia providers at 
this facility were willing to make a practice change in order to improve patient outcomes. 
Recommendations 
This project ended during step 5 of Rosswurm and Larrabee’s model for change 
to EBP. The next step would be to evaluate the effectiveness of the practice change, and 
then determine if the practice change has been maintained. In addition to the evaluation 
of this study, subsequent studies could attempt to replicate the results of this study at 
another facility or with a larger sample size. Also, future studies could examine to what 
extent these blocks decrease postoperative complications or if these blocks are effective 
at decreasing length of stay, chronic pain, or cancer recurrence. More studies are needed 
comparing other forms of relevant nerve blocks to PVBs to determine which is more 
effective. This DNP project focused on implementing nerve blocks for patients 
undergoing a bilateral mastectomy. A continuation of this project could be to create a 
practice change at other facilities to provide nerve blocks for all types of mastectomies.  
Dissemination 
Results from this project will be disseminated to anesthesia providers at current 
clinical sites and future sites of employment. Informal conversations have already been 
held with CRNAs at a another facility that does not currently utilize nerve blocks for 
mastectomy patients regarding the results of this project. Due to the outcome of this 
project, CRNAs at the facility where nerve blocks are not performed expressed an interest 
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in administering Pecs blocks to mastectomy patients. This project will also be 
disseminated through Aquila and possibly at future conferences. 
Conclusion 
Although PVBs were not implemented at this facility, other nerve blocks were 
incorporated into the plan of care for bilateral mastectomy patients having immediate 
reconstruction. Literature shows nerve blocks can improve patient outcomes following 
surgery for breast cancer. Future studies are needed to examine to what extent these block 
decrease immediate postoperative complications and to determine their effectiveness in 
decreasing length of stay, chronic pain, and cancer recurrence. Due to the effectiveness of 
the nerve blocks at this facility, Pecs I and II blocks are now offered for all types of 
mastectomies. The results from this project can be used at other facilities to implement 
nerve blocks for patients at undergoing breast surgery for cancer.  
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 - DNP Essentials 
Table A1 
DNP Essentials 
DNP Essentials  Clinical Implications  
Essential I: Nursing Science and Theory: 
Scientific Underpinnings for Practice  
  
Theories provide a foundation for 
understanding patient’s healthcare needs 
and help to identify the best interventions 
to meet those needs (Zaccagnini & White, 
2014). The model for EBP change, 
developed by Rosenwurm and Larrabee, is 
a change theory that will be used 
implement a practice change.   
Essential II: Systems Thinking, Healthcare 
Organizations, and the Advanced Practice 
Nurse Leader  
  
This essential guides DNP nurses to assess 
current healthcare policies and create 
policies that improve healthcare outcomes 
at an organizational level (Zaccagnini & 
White, 2014). For example, this project 
aims to create a practice change to 
incorporate PVBs for patients undergoing 
a bilateral mastectomy in order to improve 
postoperative outcomes.   
Essential III: Clinical Scholarship and 
Analytical Methods for Evidence-Based 
Practice  
Involves research translation and the 
dissemination and implementation of new 
knowledge (American Association of 
Colleges of Nursing [AACN], 2006). A 
review of literature found PVBs can 
improve postoperative outcomes for 
mastectomy patients (Schnabel et al., 
2010, p 8). These findings will be 
disseminated to CRNA’s to improve 
practice.   
Essential IV: Information 
Systems/Technology and Patient Care 
Technology for the Improvement and 
Transformation of Health Care  
  
This essential ensures DNP nurses are 
proficient in the use of healthcare 
technology to “create web-based learning 
or intervention tools to support and 
improve patient care” (Zaccagnini & 
White, 2014, p. 134). One of the goals for 
this project is to create a website to inform 
anesthesia providers about the benefits of 
PVBs.   
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Essential V: Healthcare Policy for Advocacy 
in Healthcare  
  
The purpose of this project is to change 
healthcare policy by disseminating 
evidence based information to the CRNAs 
at a facility in Mississippi.   
Essential VI: Interprofessional Collaboration 
for Improving Patient and Population Health 
Outcomes  
  
Through collaboration with physicians, 
anesthesiologist, and CRNAs PVBs can be 
implemented for patients undergoing a 
bilateral mastectomy with immediate 
reconstruction to decrease length of stay, 
improve postoperative outcomes, and 
increase patient satisfaction.   
Essential VII: Clinical Prevention and 
Population Health  
  
The goal of this essential is to promote 
patient health and prevent illness/disease 
(AACN, 2006). Studies have shown PVBs 
can decrease the incidence of chronic pain 
and possibly cancer recurrence (Schnabel 
et al., 2010, p 8). Educating anesthesia 
providers about the benefits of PVBs can 
lead to implementation PVBs and improve 
the health of mastectomy patients.  
Essential VIII:  Traditional Advanced Practice 
Roles for the DNP  
This project meets Essential VIII by 
educating anesthesia providers on 
evidence based findings in order to 
improve clinical practice.  
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 – Synthesis Matrix 
Table A2 
Synthesis Matrix 
  
Author/Year Postoperative Pain Postoperative 
Nausea/Vomiting 
Chronic Pain Length of Stay Cancer 
Recurrence 
Agarwal, R., 
Wallace, A., 
Madison, S., 
Morgan, A., 
Mascha, E., & 
Ilfeld, B. (2015, 
April).  
Patients receiving a 
PVB had significantly 
lower pain scores than 
patients who did not 
receive a PVB 
immediately after 
surgery. However, at 
noon on POD1 there 
was not a statistically 
significant decrease in 
pain scores in the PVB 
group. 
    
Aufforth, R., Jain, 
J., Morreale, J., 
Baumgarten, R., 
Falk, J., & 
Wessen, C. (2012).  
Patients having 
immediate 
reconstruction with a 
PVB used less opioids 
on post-op day 1 than 
the non-PVB 
reconstruction group. 
Slightly less 
postoperative 
nausea and 
vomiting (PONV) 
was noted in the 
PVB group, 3.3% 
compared to 4.2% 
in the non-PVB 
group. 
   
  
2
8
 
Beyaz, S., 
Ergonenc, T., 
Altintoprak, F., & 
Erdem, A. (2012, 
August 27).  
A thoracic PVB can 
provide better 
postoperative pain 
management and 
decrease opioid 
consumption compared 
to general anesthesia 
(GA). 
A PVB prevents 
PONV better than 
GA. 
Many of the studies 
demonstrated a 20-
50% reduction in 
chronic post 
mastectomy pain 
PVB can 
decrease the 
length of 
hospital stay 
and increase 
patient 
satisfaction 
Cited findings 
by Exadaktylos, 
A., Buggy, D., 
Moriarty, D., 
Mascha, E., & 
Sessler, D. 
(2006) 
Bhuvanseswari, 
V., Wig, J., 
Mathew, P., & 
Singh, G. (2012). 
Intraoperatively, 
patients in the 0.25% 
bupivacaine + epi + 
fentanyl and the 0.5% 
bupivacaine + epi 
groups was less than 
the 0.25% bupivacaine 
+epi and the group who 
received no PVB. 
Patients receiving a 
PVB with 0.25% 
bupivacaine + 
epinephrine + fentanyl 
and the group receiving 
a PVB with 0.5% 
bupivacaine + epi had 
significantly better 
postoperative analgesia 
compared to the group 
receiving GA alone.   
PONV was not 
statistically 
significant 
   
  
2
9
 
Bolin, E., Harvey, 
N., & Wilson, S. 
(2015, March 31) 
  Less chronic pain at 
one, six, and 12 
months reported in 
patients who 
received a PVB 
compared to those 
receiving GA alone.  
  
Boughey, J., 
Goravanchi, F., 
Parris, R., Kee, S., 
Frenzel, J., Hunt, 
K., ... Lucci, A. 
(2009, September-
October). 
The patients receiving a 
PVB reported less pain 
in the immediate 
postop period which 
continued until the next 
day for patients 
undergoing a total 
mastectomy and/or 
axillary node 
dissection. Immediately 
postop, 81% of patients 
receiving a PVB 
reported a pain score of 
0 compared to 57% of 
the non-PVB group. At 
4 hours postop, 71% of 
the PVB group reported 
a pain score of 0 
compared to 38% of 
the non-PVB group. At 
8 hours postop, 60% of 
the PVB group and 
36% of the non-PVB 
The difference in 
PONV was not 
statistically 
significant. 
 Length of stay 
(LOS) for 
patients having 
a total 
mastectomy or 
more extensive 
breast surgery 
was 
significantly 
less for those 
who received a 
PVB.  Patients 
undergoing 
extensive breast 
surgery were 
less likely to 
require an 
overnight 
hospital stay if 
they received a 
PVB. 
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0
 
group reported a pain 
score of 0.  
 
Coopey, S., 
Specht, M., 
Warren, L., Smith, 
B., Winograd, J., 
& Fleischmann, K. 
(2013, April). 
The PVB group was 
converted to oral 
narcotics sooner than 
the non-PVB group.  
Incidence of nausea 
and vomiting was 
significantly less in 
the PVB group 
compared to the 
non-PVB group. 
 Mean LOS was 
significantly 
less in the PVB 
group, which 
was 42 hours 
compared to 47 
hours in the 
non-PVB 
group. 
 
Exadaktylos, A., 
Buggy, D., 
Moriarty, D., 
Mascha, E., & 
Sessler, D. (2006, 
October).  
    Patients in the 
PVB with GA 
group had less 
cancer 
recurrence/ 
metastasis 
(3/50) 
compared to the 
GA group 
(19/50). 
Additionally, 
the PVB with 
GA group had a 
slower time to 
recurrence than 
the GA group. 
Fahy, A., Jakub, J., 
Dy, B., Eldin, N., 
Although no difference 
in pain scores was 
The amount of 
patients requiring 
 Patients in the 
non-PVB group 
 
  
3
1
 
Harmsen, S., 
Sviggum, H., & 
Boughey, J. (2014, 
October) 
noted on the day of 
surgery, opioid uses 
was higher in the non-
PVB group. Patients 
undergoing immediate 
reconstruction had the 
greatest reduction in 
postoperative opioid 
use.  
postoperative 
antiemetics was 
higher in the non-
PVB group (57%) 
compared to the 
PVB group (39%). 
were discharged 
sooner than the 
PVB group. 
Fodale, D’Arrigo, 
Triolo, Mondello, 
& La Torre. (2014) 
    Surgery is 
stressful and 
studies show 
after surgery 
recurrence of 
neoplastic 
disease can 
occur. Volatile 
anesthetics can 
decrease 
immune 
function and 
pain can 
prevent immune 
surveillance, 
and opioids can 
inhibit cellular 
and humoral 
immunity.  
Regional 
anesthesia can 
  
3
2
 
block the 
body’s 
neuroendocrine 
response to 
surgical stress 
by blocking 
transmission of 
neuronal signals 
to the central 
nervous system. 
Locoregional 
anesthesia can 
help preserve 
natural killer 
(NK) cell 
function and 
decrease the 
amount of GA 
required 
intraoperatively. 
PVB anesthesia 
is associated 
with lower risk 
of cancer 
recurrence. 
Glissmyer, C., 
Johnson, W., 
Sherman, B., 
Glissmeyer, M., 
Garreau, J., & 
Ninety-one patients 
were included in this 
study. The 51 patients 
not having 
reconstruction had an 
  Average LOS 
was less (1.3 
days) for the 
reconstruction 
group with PVB 
 
  
3
3
 
Johnson, N. 
(2015).  
average morphine 
equivalent (MSE) of 
37.9. Of the 40 patients 
undergoing 
reconstruction, 33 
received a PVB with an 
average MSE 42.6, and 
7 received only GA 
with an average MSE 
of 71.1. 
compared to the 
reconstruction 
group with no 
PVB (2 days). 
Karmakar, M., 
Samy, W., Li, J., 
Lee, A., Chan, W., 
Chen, P., & Ho, A. 
(2014, July-Aug) 
  Patients who 
receive a TPVB 
report less severe 
chronic pain, 
exhibit fewer 
symptoms and 
signs of chronic 
pain, and also 
experience better 
physical and mental 
health related 
quality of life 
(HQROL). 
  
Parikh, Sharma, 
Guffey, & 
Myckatyn, (2016) 
Breast cancer patients 
undergoing a 
mastectomy with  
autologous breast 
reconstruction who 
received a PVB were 
needed less IV opioids 
  LOS was 
significantly 
less (mean of 
95hrs) for the 
PVB group 
compared to the 
non-PVB group 
 
  
3
4
 
postoperatively, were 
converted to oral 
narcotics sooner,  and 
had less pain at 2 and 
24 hours compared to 
the non-PVB group. 
(mean of 
116hrs). 
Pei, L., Zhou, Y., 
Tan, G., Mao, F., 
Yang, D., Guan, J., 
... Huang, Y. 
(2015, November 
20).  
Patients receiving a 
PVB with propofol 
anesthesia required less 
sevoflurane, less 
intraoperative fentanyl, 
and had less 
postoperative pain than 
patients who received 
GA. However, patients 
in the PVB with 
propofol anesthesia 
group required more 
propofol than the GA 
group. 
    
Schnabel, A., 
Reichl, S. U., 
Kranke, P., 
Pogatzki-Zahn, E. 
M., & Zhan, P. K. 
(2010, October, 
14). 
There was significantly 
lower pain scores at 
rest in the 2-24 hour 
period and lower pain 
scores at movement for 
all time intervals in the 
group that received a 
PVB in addition to GA 
compared to the group 
that received GA alone. 
Patients receiving 
only a PVB had 
less PONV than 
women undergoing 
surgery with GA. 
Relative risk for 
chronic pain was 
lower in the PVB 
group 6 months 
after surgery. 
Twelve months 
after surgery two 
studies reported a 
lower chronic pain 
when patients had a 
 Evidence 
indicates 
surgery can 
release tumor 
cells into 
circulation, 
volatile 
anesthetics can 
impair immune 
function, 
  
3
5
 
The number of patients 
requiring postop 
opioids was 
significantly lower in 
the PVB group. 
PVB in addition to 
GA. 
opioids can 
further impair 
immune 
function and 
promote 
angiogenic 
factors, and 
pain alone is 
associated with 
cancer 
recurrence. This 
study shows 
patients 
receiving a 
PVB in addition 
to GA or alone 
required less 
postoperative 
pain 
medications, 
which could 
indicate a 
decreased 
incidence of 
cancer 
recurrence. 
Shimizu, H., 
Kamiya, Y., 
Nishimaki, H., 
Forty-nine patients 
were included in the 
study. The dose of 
remifentanil used 
 Patients who 
reported chronic 
pain had 
significantly higher 
  
  
3
6
 
Denda, S., & 
Baba, H. (2015).  
intraoperatively was 
less in the PVB group. 
Pain scores were 
significantly lower 6-
24 hours 
postoperatively for 
patients who received a 
PVB. However, even 
though pain scores 
tended to be lower in 
the PVB group, no 
statistical significance 
was found in pain 
scores 0-6 hours after 
surgery and 24 hours 
after surgery. 
pain scores 3-6 
hours 
postoperatively. 
The incidence of 
chronic pain was 
significantly less 1 
year postop for the 
PVB group (5/23) 
compared to the 
group receiving GA 
alone (12/23).  
Tahiri, Y., Tran, 
D., Bouteaud, J., 
Xu, L., Lalonde, 
D., Luc, M., & 
Nikolis, A. (2011).  
Nine of the 11 studies 
reported a complication 
rate less than 2.6%. 
The PVB group 
reported less pain than 
the general anesthetic 
group, and 
postoperative opioid 
consumption was less 
in the PVB group 
compared to the 
general anesthetic 
group. 
    
  
3
7
 
Terkawi, A., 
Tsang, S., Sessler, 
D., Terkawi, R., 
Nunemaker, M., 
Durieux, M., & 
Shilling, A. (2015, 
September/Octobe
r).  
Pain at rest and 
movement was 
modestly but 
significantly less for 
the PVB group at 2, 24, 
48, and 72 hours after 
surgery. The addition 
of fentanyl to local 
anesthetic decreased 
pain with movement in 
the PVB group at 24 
and 72 hours. 
Intraoperative and 
postoperative opioid 
use was significantly 
less for those who 
received a PVB 
compared to the control 
group with 
heterogeneity.  
A statistically 
significant decrease 
in PONV with 
heterogeneity was 
noted in the PVB 
group. 
Patients who 
received a PVB 
reported 
significantly less 
chronic pain at 6 
months with no 
heterogeneity 
noted. 
A statistically 
significant 
decrease in 
LOS was found 
for the PVB 
group with 
heterogeneity. 
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 – Paravertebral Block Protocol 
Candidates: Women diagnosed with breast cancer undergoing a bilateral mastectomy 
with immediate reconstruction 
Indication: To decrease postoperative pain, nausea/vomiting, and hospital length of stay 
for patients undergoing a bilateral mastectomy with immediate reconstruction 
 
Absolute Contraindications: 
• Patient refusal 
• Local anesthetic allergy 
• Infection near injection site 
• Tumor at injection site 
• Severe hypovolemia 
Relative Contraindications: 
• Severe coagulopathy 
• Severe respiratory disease 
• Spinal deformities 
• Unspecified neuropathy 
Supplies: 
• Emergency airway equipment 
• Emergency drugs (including 20% intralipids) 
• Ultrasound machine 
• Nerve stimulator  
• Sterile gloves 
• Skin prep solution 
• Lidocaine and 25-gauge needle for local injection 
• 22-gauge nerve block needle or spinal needle 
• 0.5% bupivacaine  
• 1:200,000 epinephrine 
Benefits: 
• Postoperative pain control 
• Decreased postoperative nausea/vomiting 
• Decreased hospital length of stay 
• Decreased incidence of chronic pain 
Table A3 
Paravertebral Block Protocol 
Patient Preparation 
• Verify patient name and date of 
birth 
 
• NIBP, O2saturation, HR, respiratory 
rate, CBC 
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• Obtain vital signs and review 
pertinent lab work 
• Obtain informed consent 
• Include risks and benefits associated 
procedure 
Process 
• Premedicate patient with Versed (1-
3 mg IV) and Fentanyl (25-100 
mcg) 
• Place patient in sitting position 
• Ultrasound guided PVB at T1, T3, 
and T5 using 0.5% bupivacaine 
with 1:200,000 epinephrine.  
o Inject 3-5ml at each level 
bilaterally (not to exceed 
30ml or 3mg/kg) 
 
 
 
 
 
• Neck flexed with chin to chest, 
shoulders in a collapsed position, and 
back arched 
• Begin scanning 5-10 cm laterally to 
identify ribs and pleura. Move 
transducer medially until transverse 
processes are identified. Once 
transverse processes have been 
identified, insert needle out-of-plane 
until the transverse process is 
contacted. Then, direct needle caudad 
(approximately 1-1.5 cm) into the 
paravertebral space. Aspirate and 
inject 3-5 ml of local anesthetic. 
Repeat this procedure for each level 
to be blocked. Injection of local 
anesthetic should result in 
displacement of the pleura. 
• If a nerve stimulator is used begin 
with current at 2-2.5mA with the goal 
of eliciting an intercostal muscle 
twitch. Observe twitch and decrease 
mA to 0.8 while advancing needle 
into paravertebral space.  
Post Procedure Care 
• Monitor patient for 30 minutes after 
block for complications, 
hypotension, and anesthetic 
toxicity. 
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 – Initial Questionnaire 
Initial Questionnaire 
 
1. What is your age  
 
 
2. What is your gender 
□ Male  □ Female 
 
3. How long have you been an anesthesia provider? 
 
 
4. How many times did you provide anesthesia for a patient undergoing a bilateral 
mastectomy with immediate reconstruction in the past month? 
 
 
5. How many times did you perform a paravertebral block for these patients? 
 
 
6. Of the patients undergoing a bilateral mastectomy with immediate reconstruction, 
how many times was a paravertebral block contraindicated? 
 
 
7. Was the information provided on paravertebral blocks relevant to your practice? 
□ Yes 
□ No 
 
8. If a paravertebral block was performed (select all that apply) 
  □ For the majority of patients a paravertebral block was beneficial  
 □ A paravertebral block was not beneficial  
□ Overall, the paravertebral blocks were easy to perform 
□ The paravertebral blocks were not easy to perform 
□ I will continue to administer paravertebral blocks for these patients 
□ I will not continue to perform paravertebral blocks for these patients 
□ Other                                                                                                           
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 – Follow-up Questionnaire 
Follow-up Questionnaire 
 
1. What is your age  
 
2. What is your gender 
□ Male  □ Female 
 
3. How long have you been an anesthesia provider? 
 
4. How many times did you provide anesthesia for a patient undergoing a bilateral 
mastectomy with immediate reconstruction in the past month? 
 
5. How many of these patients received a paravertebral block in addition to general 
anesthesia? 
 
6. How many of these patients received a pecs block in addition to general 
anesthesia? 
 
7. At what phase of patient care was the nerve block provided? 
□ Preoperative 
□ Intraoperative 
□ Postoperative 
 
8. Did the patients who received a nerve block experience less postoperative 
complications than those who received only general anesthesia? 
□ Yes 
□ No 
 
9. Was regional anesthesia used as the sole anesthetic for any of the patients 
undergoing a bilateral mastectomy with immediate reconstruction? 
□ Yes 
□ No 
 
10. Will you continue to perform nerve blocks for this patient population? 
□ Yes 
□ No 
 
11. Of the patients undergoing a bilateral mastectomy with immediate reconstruction, 
how many times was a nerve block contraindicated? 
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 – IRB Approval Letter 
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 – Facility Approval Letter 
 
  
4
4
 
 – Logic Model 
Table A4 
Logic Model 
Inputs Activities Outputs Outcomes 
Initial Long-term Impact 
Facilities – OR 
rooms 
 
Staff – CRNAs, 
anesthesiologist, 
surgeons 
 
Equipment – 
monitors, 
emergency airway 
equipment 
 
Supplies – 
equipment for 
block, medications 
 
 
Search databases 
such as PubMed, 
CINAHL, Primo at 
The University of 
Southern 
Mississippi, 
clinicaltrials.gov, 
and MEDLINE 
regarding different 
methods of 
administering 
anesthesia for 
patients undergoing 
a bilateral 
mastectomy with 
immediate 
reconstruction.  
 
Collect data about 
the postoperative 
Provide education 
on the benefits of 
PVBs to patients, 
physicians, and 
anesthesia staff 
 
Implement a 
policy for routine 
administration of 
PVBs for patients 
undergoing a 
bilateral 
mastectomy with 
immediate 
reconstruction 
 
Provider 
Outcomes 
Anesthesia 
providers will 
adequately 
administer PVBs 
to patients 
undergoing breast 
surgery with 
immediate 
reconstruction 
 
Patient Outcomes 
Patients have 
decreased 
postoperative 
nausea and 
vomiting 
following surgery 
Provider 
Outcomes 
Anesthesia 
providers will 
routinely 
administer PVBs 
to  patients 
undergoing breast 
surgery with 
immediate 
reconstruction 
 
Anesthesia 
providers will 
experience 
satisfaction when 
administering 
PVBs to these 
patients. 
 
Improved quality 
of life for 
bilateral 
mastectomy 
patients having 
immediate 
reconstruction 
 
  
4
5
 
outcomes of 
mastectomy 
patients undergoing 
a mastectomy with 
immediate 
reconstruction, like 
the level of 
postoperative pain, 
nausea, and 
vomiting  
 
Collect data about 
the cost of different 
methods of 
anesthesia 
 
Analyze data in 
order to determine 
if administration of 
a PVB compared to 
other methods of 
anesthesia would 
be beneficial and 
cost effective for 
mastectomy 
patients undergoing 
a bilateral 
mastectomy with 
immediate 
reconstruction 
when PVB are 
used 
 
Patients will be 
discharged earlier 
 
 
Hospital 
Hospital 
expenditure on 
narcotics will 
decrease 
 
Revenue will 
increase 
 
 
Patient Outcomes 
Long term –  
Decreased 
incidence of 
chronic pain 
 
Decreased 
incidence of 
cancer 
 
 
 
 
Hospital 
Decreased use of 
medical 
equipment and 
earlier discharge 
of patients will 
decrease cost to 
the hospital 
 
  
4
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Develop a policy to 
implement PVBs 
patients undergoing 
a mastectomy with 
immediate 
reconstruction if 
they are shown to 
be beneficial  
 
Inform CRNAs 
about online 
training for 
administration of 
PVBs 
Assumptions 
-The postoperative care of bilateral mastectomy patients’ needs to be improved   
- Patients will agree to have a PVB        
- CRNAs will be authorized by the facility to administer PVBs 
- Anesthesia providers will attend the in-service                                                                     
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